Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3,5-trimethoxybenzene
1. 4463-03-0
2. 2,4,6-trimethylbenzene-1,3,5-triol
3. Trimethylphloroglucin
4. 2,4,6-trimethyl-1,3,5-benzenetriol
5. 2,4,6-trimethylphloroglucinol
6. Trimethyl Phloroglucino
7. Schembl320898
8. Trimethylbenzene-1,3,5-triol
9. Dtxsid80196258
10. Zinc3650253
11. Ft-0675631
12. A936958
Molecular Weight | 168.19 g/mol |
---|---|
Molecular Formula | C9H12O3 |
XLogP3 | 1.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | 168.078644241 g/mol |
Monoisotopic Mass | 168.078644241 g/mol |
Topological Polar Surface Area | 60.7 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 113 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Registrant Name : Bansen Co., Ltd.
Registration Date : 2021-12-03
Registration Number : 20211203-209-J-1169
Manufacturer Name : Patheon Austria GmbH & Co KG
Manufacturer Address : St. Peter Strasse 25, 4020 Linz Austria
About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities ar...
About the Company : Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was e...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Reply
22 Jul 2024
Reply
01 Jul 2024
Reply
20 Mar 2023
Reply
28 Oct 2021
Reply
31 May 2021
Reply
30 Apr 2021
Reply
02 Mar 2020
Reply
20 Nov 2019
ABOUT THIS PAGE
A Trimethylphloroglucinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimethylphloroglucinol, including repackagers and relabelers. The FDA regulates Trimethylphloroglucinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimethylphloroglucinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimethylphloroglucinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimethylphloroglucinol supplier is an individual or a company that provides Trimethylphloroglucinol active pharmaceutical ingredient (API) or Trimethylphloroglucinol finished formulations upon request. The Trimethylphloroglucinol suppliers may include Trimethylphloroglucinol API manufacturers, exporters, distributors and traders.
click here to find a list of Trimethylphloroglucinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trimethylphloroglucinol Drug Master File in Korea (Trimethylphloroglucinol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trimethylphloroglucinol. The MFDS reviews the Trimethylphloroglucinol KDMF as part of the drug registration process and uses the information provided in the Trimethylphloroglucinol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trimethylphloroglucinol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trimethylphloroglucinol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trimethylphloroglucinol suppliers with KDMF on PharmaCompass.
Trimethylphloroglucinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimethylphloroglucinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimethylphloroglucinol GMP manufacturer or Trimethylphloroglucinol GMP API supplier for your needs.
A Trimethylphloroglucinol CoA (Certificate of Analysis) is a formal document that attests to Trimethylphloroglucinol's compliance with Trimethylphloroglucinol specifications and serves as a tool for batch-level quality control.
Trimethylphloroglucinol CoA mostly includes findings from lab analyses of a specific batch. For each Trimethylphloroglucinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimethylphloroglucinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimethylphloroglucinol EP), Trimethylphloroglucinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimethylphloroglucinol USP).
LOOKING FOR A SUPPLIER?